[Erythema multiforme. A heterogeneous pathologic phenotype]
- PMID: 10434539
[Erythema multiforme. A heterogeneous pathologic phenotype]
Abstract
The term Erythema Multiforme (EM) include actually a wide range of clinical expressions, from exclusive oral erosions (Oral EM) to mucocutaneous lesions (EM Minor), sometimes with severe involvement of multiple mucosal membrane (EM major, Stevens-Johnson syndrome [SJS]) or with involvement of a large area of the total body surface (toxic epidermal necrolysis [TEN]). However, this terminology is not worldwide accepted and often the various clinical categories show some overlapping features. Among the great number of suspected etiological factors, herpes simplex virus is involved in many cases of EM minor whereas SJS and TEN are caused in 80% of cases by systemic drugs, mainly by anticonvulsivants, sulfonamides, nonsteroidal anti-inflammatory drugs and antibiotics. Several oral EM seem idiopathic, but data on this topic are very few. There is no specific or consistent microscopic and immunopathologic pattern of EM and the diagnosis should be done by excluding other similar diseases. The treatment include the use of antivirals for EM minor, mainly if recurrent, and of immunosuppressants (especially systemic corticosteroids) for SJS. TEN patients require adequate supportive care and often they have to be treated in emergency departments. Finally, patients with exclusive oral lesions may be treated with both topical and systemical corticosteroids.
Similar articles
-
Oral mucosal diseases: erythema multiforme.Br J Oral Maxillofac Surg. 2008 Mar;46(2):90-5. doi: 10.1016/j.bjoms.2007.07.202. Epub 2007 Sep 4. Br J Oral Maxillofac Surg. 2008. PMID: 17767983
-
Mucosal disease series. Number IV. Erythema multiforme.Oral Dis. 2005 Sep;11(5):261-7. doi: 10.1111/j.1601-0825.2005.01141.x. Oral Dis. 2005. PMID: 16120111
-
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.Arch Dermatol. 1990 Jan;126(1):43-7. Arch Dermatol. 1990. PMID: 2404462
-
Erythema multiforme and related disorders.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 May;103(5):642-54. doi: 10.1016/j.tripleo.2006.12.008. Epub 2007 Mar 6. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007. PMID: 17344075 Review.
-
Erythema multiforme.Am Fam Physician. 1992 Oct;46(4):1171-6. Am Fam Physician. 1992. PMID: 1414882 Review.
Cited by
-
A rare thymoma case with seven paraneoplastic syndromes.Int J Clin Exp Med. 2015 Oct 15;8(10):19517-23. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26770603 Free PMC article.
-
Treatment of recurrent erythema multiforme with adalimumab as monotherapy.JAAD Case Rep. 2017 Mar 2;3(2):95-97. doi: 10.1016/j.jdcr.2016.11.009. eCollection 2017 Mar. JAAD Case Rep. 2017. PMID: 28280768 Free PMC article. No abstract available.
-
Drug induced exfoliative dermatitis: state of the art.Clin Mol Allergy. 2016 Aug 22;14(1):9. doi: 10.1186/s12948-016-0045-0. eCollection 2016. Clin Mol Allergy. 2016. PMID: 27551239 Free PMC article. Review.
-
A Case Report on an Elusive Incident of Erythema Multiforme.J Educ Teach Emerg Med. 2025 Jan 31;10(1):V17-V21. doi: 10.21980/J8BM0W. eCollection 2025 Jan. J Educ Teach Emerg Med. 2025. PMID: 39926249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical